A novel pen-based Bluetooth-enabled insulin delivery system with insulin dose tracking and advice
A novel pen-based Bluetooth-enabled insulin delivery system with insulin dose tracking and advice
复制标题
DOI：
10.1080/17425247.2017.1313831
复制
发表时间：
2017-05-01
影响因子：
6.6
通讯作者：
Stone, Jenine Y.
中科院分区：
文献类型：
--
作者：
Bailey, Timothy S.;Stone, Jenine Y.
导读：糖尿病在国际上的患病率正在上升。随着越来越多的人需要胰岛素作为其治疗的一部分，技术的发展优化了递送，提高了依从性，减少了剂量错误。胰岛素笔在简单性、剂量准确性和用户偏好方面优于小瓶和注射器。丸顾问提高给药信心和治疗依从性。InPen系统提供了一种新颖的治疗方法，通过无线笔与具有剂量顾问的移动应用程序同步，实现方便的胰岛素剂量跟踪和更准确的剂量建议以及其他功能。涵盖领域：综述了现有的胰岛素输送技术和注射建议。描述了InPen设备的机制和功能。报告了InPen系统形成性测试和可用性研究的结果。讨论了InPen系统在糖尿病治疗中的未来发展方向。专家意见：糖尿病管理是复杂的，很大程度上是数据驱动的。InPen系统提供了一个有希望的新机会，利用胰岛素笔使用者已知的特性来提高治疗效果，否则主要是那些使用泵的人。鉴于大多数胰岛素使用者不使用胰岛素泵，InPen系统有望改善很大一部分糖尿病人群的血糖控制。
Introduction: Diabetes is growing in prevalence internationally. As more individuals require insulin as part of their treatment, technology evolves to optimize delivery, improve adherence, and reduce dosing errors. Insulin pens outperform vial and syringe in simplicity, dosing accuracy, and user preference. Bolus advisors improve dosing confidence and treatment adherence. The InPen System offers a novel approach to treatment via a wireless pen that syncs to a mobile application featuring a bolus advisor, enabling convenient insulin dose tracking and more accurate bolus advice among other features.Areas covered: Existing technology for insulin delivery and bolus advice are reviewed. The mechanics and functionality of the InPen device are delineated. Findings from formative testing and usability studies of the InPen system are reported. Future directions for the InPen system in the treatment of diabetes are discussed.Expert opinion: Diabetes management is complex and largely data-driven. The InPen System offers a promising new opportunity to avail insulin pen-users of features known to improve treatment efficacy, which have otherwise primarily been available to those using pumps. Given that the majority of insulin users do not use insulin pumps, the InPen System is poised to improve glucose control in a significant portion of the diabetes population.